ENTITY
Acadia Pharmaceuticals

Acadia Pharmaceuticals (ACAD US)

24
Analysis
Health CareUnited States
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.
more
Refresh
Company Presentation09 May 2024 04:30
Company Presentation09 Aug 2018 05:00
Company Presentation07 Nov 2018 06:00
Company Presentation27 Feb 2019 06:00
Company Presentation02 May 2019 04:30
x